Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine Add-On for Bipolar Disorder and Cocaine Dependence
NCT00223210Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Nov 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bipolar I disorder and cocaine dependence comparing Quetiapine Add-On with Placebo Add-On (2 arms). Primary endpoints: Cocaine Use at 12 weeks, Cocaine Use (Self-Report) at 12 weeks and 3 more. Started Nov 2005; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar I disordercocaine dependence
Beyond the preview
Go deeper on NCT00223210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00223210.